EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Electroacupuncture Inhibits Neuronal Ferroptosis in MCAO/R Model Mice by Regulating the GSK-3β/NRF2 Signaling Pathway

Wenxin Xia, Rui Zhao, Xiaoxiao Li, Chenchen Xu, Jianjian Dong, Shujie Li, Yun Xu, Yongsheng Han

Journal of Integrative Neuroscience · 2026-10-13 · 25 (10)

DOI: 10.31083/jin53689 ↗
AbstractBibliografische Angaben

Abstract

Background: Neuronal ferroptosis following acute ischemic stroke (AIS) contributes to ischemic brain injury and is regulated by nuclear factor erythroid 2-related factor 2 (NRF2), a key regulator of antioxidant defense and iron homeostasis. Whether electroacupuncture (EA) suppresses neuronal ferroptosis by regulating NRF2 stability and nuclear translocation through upstream glycogen synthase kinase 3 beta (GSK-3β) remains unclear. We investigated whether EA inhibits neuronal ferroptosis and alleviates ischemic brain injury by modulating the GSK-3β/NRF2 axis. Methods: Middle cerebral artery occlusion/reperfusion (MCAO/R) models were established in C57BL/6 and conditional Nrf2-knockout mice. The GSK-3β inhibitor laduviglusib (CHIR-99021; CHIR), the ferroptosis inhibitor ferrostatin-1 (Fer-1), and conditional Nrf2 knockout were used to investigate the anti-ferroptotic mechanism of EA and the regulatory hierarchy between GSK-3β and NRF2. Reverse transcription quantitative polymerase chain reaction (RT-qPCR), western blotting, and immunofluorescence were used to examine the GSK-3β/NRF2 pathway and ferroptosis-related molecules. NRF2 nuclear localization, neuronal nuclei (NeuN) /acyl-CoA synthetase long-chain family member 4 (ACSL4) double immunofluorescence, and co-immunoprecipitation were used to assess NRF2 nuclear translocation, neuronal ferroptosis, and the GSK-3β–NRF2 interaction, respectively. Results: EA inhibited GSK-3β activity after MCAO/R, restored NRF2 protein expression, promoted nuclear accumulation, and upregulated NAD(P)H:quinone oxidoreductase 1 (NQO1). EA also downregulated ACSL4 and transferrin receptor 1 (TfR1), upregulated glutathione peroxidase 4 (GPX4) and solute carrier family 7 member 11 (SLC7A11), reduced NeuN/ACSL4-colocalized neurons, decreased ferrous iron (Fe2+) and malondialdehyde (MDA) levels, and increased superoxide dismutase (SOD) activity, glutathione (GSH) content, and the GSH/oxidized glutathione (GSSG) ratio. CHIR and Fer-1 produced similar anti-ferroptotic effects, and co-immunoprecipitation confirmed GSK-3β–NRF2 interaction. Conditional Nrf2 knockout did not affect EA- or CHIR-mediated GSK-3β phosphorylation but markedly attenuated their effects on NQO1, SLC7A11, GPX4, and TfR1. EA also alleviated mitochondrial ultrastructural damage, reduced cerebral infarction and Fluoro-Jade B (FJB)-positive neurons, and improved neurological function and motor coordination in MCAO/R mice. Conclusion: These findings identify the GSK-3β/NRF2 axis as an important regulatory mechanism of regulating neuronal ferroptosis after MCAO/R and support EA as a potential therapeutic strategy for alleviating neuronal ferroptosis and cerebral ischemia-reperfusion injury through GSK-3β inhibition and NRF2 activation.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →